On the Road – Tesla Style

 

Let’s talk about Tesla. The electric car company founded in 2003 has arguably made headlines nearly every year since their first production of an EV, the Roadster, in 2008. And despite the sharp and steady decline in stock market value over the past nine months, Tesla has posted strong Q4 sales, in fact, the highest in the world.

       So, what is happening behind the scenes to make Tesla stock fall short of expectations? For one, the man behind the curtain is rattling some cages with various business holdings, *cough* Twitter *cough*.

Here to share his thoughts on Tesla’s current situation and look toward the future is Clyde Boyce, Chairman of Advisory Board, EV Chargers and Installation LLC.

Clyde’s Thoughts:

“Good afternoon. Let’s talk a little bit about what’s going on with Tesla right now. As we all know, Tesla is more than just an EV car manufacturer. They have the largest charging network in the country and the most powerful charging network in the country. They have the cyber truck. They’re beginning to produce semi-trucks.

They have pretty much dropped out of the autonomous car business, but they also manufacture batteries. They have worldwide partnerships with the production of batteries. The company in of itself has the highest margin on the sale of cars of any company in the world. And they had the highest sales in December in the fourth quarter of any car company in the world. So they’re doing just fine now in terms of the stock having dropped 75% in about the last nine months. Why? Because Tesla’s having production issues because many people are upset with Mr. Musk for taking his eye off the ball on Tesla for Twitter, and they don’t really like that. They think that’s having an effect on the car company, which truly it probably isn’t.

So I don’t think anybody really needs to worry too much about the stock coming back. I think it will, and I don’t think they need to worry at all about Mr. Musk going from the number one most valuable man in the world to number two. He’s going to be fine as well. Thank you.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More